Update: Studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 6, 2013, Pages 1150-1156

  Swerdlow, Neal R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal ganglia; Dopamine; Prepulse inhibition; Sensorimotor gating; Startle reflex; Tourette Syndrome

Indexed keywords

CARBOXYLASE; DOPAMINE; FINASTERIDE; HISTIDINE CARBOXYLASE; UNCLASSIFIED DRUG;

BASAL GANGLION; BEHAVIOR THERAPY; BIOLOGICAL MODEL; COGNITIVE THERAPY; COMPREHENSIVE BEHAVIORAL INTERVENTIONS FOR TICS; CONNECTOME; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; FOREBRAIN; GILLES DE LA TOURETTE SYNDROME; HUMAN; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREPULSE INHIBITION OF STARTLE REFLEX; PRIORITY JOURNAL; REVIEW; SENSORY GATING; STIMULUS RESPONSE; TREATMENT RESPONSE; ANIMAL; DISEASE MODEL; INHIBITION (PSYCHOLOGY); PHYSIOLOGY; STARTLE REFLEX;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INHIBITION (PSYCHOLOGY); SENSORY GATING; STARTLE REACTION; TOURETTE SYNDROME; REFLEX, STARTLE;

EID: 84880927039     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.09.002     Document Type: Review

References (87)

1. Ahmari S.E., Risbrough V.B., Geyer M.A., Simpson H.B. Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology 2012, 37:1216-1223.
2. Albin R.L., Koeppe R.A., Bohnen N.I., Nichols T.E., Meyer P., Wernette K., Minoshima S., Kilbourn M.R., Frey K.A. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003, 61:310-315.
3. Alsene K.M., Rajbhandari A.K., Ramaker M.J., Bakshi V.P. Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating. Neuropsychopharmacology 2011, 36:1003-1014.
4. Amitai, N., Weber, M., Swerdlow, N.R., Sharp, R.F., Breier, M.R., Halberstadt, A.L., Young, J.W., 2012. A novel visuospatial priming task for rats with relevance to Tourette syndrome: evidence for rate-dependent effects of amphetamine. Neuroscience and Biobehavioral Reviews, in press.
5. Baldan Ramsey L.C., Williams K., Gallezot J.D., Crowley M., Anderson G., Leventhal B.I., Ohtsu H., Krystal J.H., Mayes L., De Araujo I., Ding Y.S., State M.W., Pittenger C. Histidine decarboxylase deficiency produces Tourette syndrome phenomenology and dopamine dysregulation in humans and mice. Neuropsychopharmacology 2011, 34:S198-S199.
6. Baldan Ramsey L.C., Xu M., Wood N., Pittenger C. Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience 2011, 180:222-228.
7. Belluscio B.A., Jin L., Watters V., Lee T.H., Hallett M. Sensory sensitivity to external stimuli in Tourette syndrome patients. Movement Disorders 2011, 26:2538-2543.
8. Bitsios P., Giakoumaki S.G., Frangou S. The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology 2005, 182:144-152.
9. Bliss J. Sensory experiences of Gilles de la Tourette syndrome. Archives of General Psychiatry 1980, 37:1343-1347.
10. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
11. Carasso B.S., Bakshi V.P., Geyer M.A. Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuropharmacology 1998, 37:401-404.
12. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. Journal of Neuroscience 1999, 19:3248-3257.
13. Castellanos F.X., Fine E.J., Kaysen D.L., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's Syndrome and ADHD: preliminary results. Biological Psychiatry 1996, 39:33-41.
14. Cohen D.J., Leckman J.F. Sensory phenomena associated with Gilles de la Tourette's syndrome. Journal of Clinical Psychiatry 1992, 5:319-323.
15. Davis M. NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Dialogues in Clinical Neuroscience 2011, 13:463-474.
16. Deckersbach T., Rauch S., Buhlmann U., Wilhelm S. Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behaviour Research and Therapy 2006, 44:1079-1090.
17. Devoto P., Frau R., Bini V., Pillolla G., Saba P., Flore G., Corona M., Marrosu F., Bortolato M. Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation. Psychoneuroendocrinology 2012, 37:1630-1645.
18. Eggert. P., Freischmidt, S., Bismarck, P.V., Schulz-Jürgensen, S., 2012. Differentiation of subgroups of monosymptomatic enuresis according to prepulse inhibition of the startle reflex. Acta Paediatrica, doi:10.1111/j.1651-2227.2012.02624.x.
19. Francis D.D., Szegda K., Campbell G., Martin W.D., Insel T.R. Epigenetic sources of behavioral differences in mice. Nature Neuroscience 2003, 6:445-446.
20. Frankland P.W., Wang Y., Rosner B., Shimizu T., Balleine B.W., Dykens E.M., Ornitz E.M., Silva A.J. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Molecular Psychiatry 2004, 9:417-425.
21. Frey K.A. Neuroimaging in the pursuit of Tourette syndrome neurobiology. Proceedings of the Autism Neuroimaging Summit 2006, the TSA Neuroimaging Consortium, University of California, Los Angeles.
22. Giakoumaki S.G., Roussos P., Bitsios P. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology 2008, 33:3058-3068.
23. Gomez-Wong E., Marti M.J., Tolosa E., Valls-Sole J. Sensory modulation of the blink reflex in patients with blepharospasm. Archives of Neurology 1998, 55:1233-1237.
24. Graham F. The more or less startling effects of weak prestimuli. Psychophysiology 1975, 12:238-248.
25. Greenwood T.A., Braff D.L., Light G.A., Cadenhead K.S., Calkins M.E., Dobie D.J., Freedman R., Green M.F., Gur R.E., Gur R.C., Mintz J., Nuechterlein K.H., Olincy A., Radant A.D., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Schork N.J. The Consortium on the Genetics of Schizophrenia (COGS): initial heritability analyses of endophenotypic measures for schizophrenia. Archives of General Psychiatry 2007, 64:1242-1250.
26. Hoenig K., Hochrein A., Quednow B.B., Maier W., Wagner M. Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biological Psychiatry 2005, 57:1153-1158.
27. Hollenbeck P.J. A jangling journey: life with Tourette's syndrome. Cerebrum 2003, 5:47-60.
28. Kalanithi P.S., Zheng W., Kataoka Y., DiFiglia M., Grantz H., Saper C.B., Schwartz M.L., Leckman J.F., Vaccarino F.M. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13307-13312.
29. Kataoka Y., Kalanithi P.S., Grantz H., Schwartz M.L., Saper C., Leckman J.F., Vaccarino F.M. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. Journal of Comparative Neurology 2010, 518:277-291.
30. Kodsi M.H., Swerdlow N.R. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behavioral Neuroscience 1995, 109:912-928.
31. Kodsi M.H., Swerdlow N.R. Quinolinic acid lesions of the ventral striatum reduce sensorimotor gating of acoustic startle in rats. Brain Research 1994, 643:59-65.
32. Kumari V., Premkumar P., Fannon D., Aasen I., Raghuvanshi S., Anilkumar A.P., Antonova E., Peters E.R., Kuipers E. Sensorimotor gating and clinical outcome following cognitive behaviour therapy for psychosis. Schizophrenia Research 2012, 134:232-238.
33. Leckman J.F., Bloch M.H., Smith M.E., Larabi D., Hampson M. Neurobiological substrates of Tourette's disorder. Journal of Child and Adolescent Psychopharmacology 2010, 20:237-247.
34. Leckman J.F., Hardin M.T., Riddle M.A., Stevenson J., Ort S.I., Cohen D.J. Clonidine treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry 1991, 48:324-328.
35. Leckman J.F., Walker D.E., Cohen D.J. Premonitory urges in Tourette's syndrome. American Journal of Psychiatry 1993, 150:98-102.
36. Leckman J.F., Walker D.E., Goodman W.K., Pauls D.L., Cohen D.J. Just right perceptions associated with compulsive behavior in Tourette's syndrome. American Journal of Psychiatry 1994, 151:675-680.
37. Levenga J., Hayashi S., de Vrij F.M., Koekkoek S.K., van der Linde H.C., Nieuwenhuizen I., Song C., Buijsen R.A., Pop A.S., Gomezmancilla B., Nelson D.L., Willemsen R., Gasparini F., Oostra B.A. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome. Neurobiology of Disease 2011, 42:311-317.
38. Li L., Du Y., Li N., Wu X., Wu Y. Top-down modulation of prepulse inhibition of the startle reflex in humans and rats. Neuroscience and Biobehavioral Reviews 2009, 33:1157-1167.
39. Lind N.M., Arnfred S.M., Hemmingsen R.P., Hansen A.K. Prepulse inhibition of the acoustic startle reflex in pigs and its disruption by d-amphetamine. Behavioural Brain Research 2004, 155:217-222.
40. Linn G.S., Negi S.S., Gerum S.V., Javitt D.C. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology 2003, 169:234-239.
41. Lyon G.J., Samar S.M., Conelea C., Trujillo M.R., Lipinski C.M., Bauer C.C., Brandt B.C., Kemp J.J., Lawrence Z.E., Howard J., Castellanos F.X., Woods D., Coffey B.J. Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder. Journal of Child and Adolescent Psychopharmacology 2010, 20:283-289.
42. McAlonan G.M., Daly E., Kumari V., Critchley H.D., van Amelsvoort T., Suckling J., Simmons A., Sigmundsson T., Greenwood K., Russell A., Schmitz N., Happe F., Howlin P., Murphy D.G. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 2002, 125(Pt 7):1594-1606.
43. McNaught K.S., Mink J.W. Advances in understanding and treatment of Tourette syndrome. Nature Reviews Neuroscience 2011, 7:667-676.
44. Miguel E.C., Baer L., Coffey B.J., Rauch S.L., Savage C.R., O'Sullivan R.L., Phillips K., Moretti C., Leckman J.F., Jenike M.A. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. British Journal of Psychiatry 1997, 170:140-145.
45. Miguel E.C., de Rosario-Campos M.C., Prado H.S., do Valle R., Rauch S.L., Coffey B.J., Baer L., Savage C.R., O'Sullivan R.L., Jenike M.A., Leckman J.F. Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. Journal of Clinical Psychiatry 2000, 61:150-156.
46. Mitrano D.A., Schroeder J.P., Smith Y., Cortright J.J., Bubula N., Paul Vezina P., Weinshenker D. Alpha-1 adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology 2012, 37:2161-2172. 10.1038/npp.2012.68.
47. Muroni A., Paba S., Puligheddu M., Marrosu F., Bortolato M. A preliminary study of finasteride in Tourette syndrome. Movement Disorders 2011, 26:2146-2147.
48. Neuner I., Podoll K., Lenartz D., Sturm V., Schneider F. Deep brain stimulation in the nucleus accumbens for intractable Tourette's syndrome: follow-up report of 36 months. Biological Psychiatry 2009, 65:e5-e6.
49. Olmos-Serrano J.L., Corbin J.G., Burns M.P. The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Developmental Neuroscience 2011, 33:395-403.
50. Ornitz E.M., Hanna G.L., de Traversay J. Prestimulation-induced startle modulation in attention deficit hyperactivity disorder and nocturnal enuresis. Psychophysiology 1992, 29:437-451.
51. Peterson B.S., Thomas P., Kane M.J., Scahill L., Zhang H., Bronen R., King R.A., Leckman J.F., Staib L. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Archives of General Psychiatry 2003, 60:415-424.
52. Piacentini J., Woods D.W., Scahill L., Wilhelm S., Peterson A.L., Chang S., Ginsburg G.S., Deckersbach T., Dziura J., Levi-Pearl S., Walkup J.T. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 2010, 303:1929-1937.
53. Posch D.K., Schwabe K., Krauss J.K., Lütjens G. Deep brain stimulation of the entopeduncular nucleus in rats prevents apomorphine-induced deficient sensorimotor gating. Behavioural Brain Research 2012, 232:130-136.
54. Ralph R.J., Caine S.B. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. Journal of Pharmacology and Experimental Therapeutics 2005, 312:733-741.
55. Ralph R.J., Paulus M.P., Geyer M.A. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. Journal of Pharmacology and Experimental Therapeutics 2001, 298:148-155.
56. Singer H.S., Giuliano J.D., Hansen B.H., Hallett J.J., Laurino J.P., Benson M., Kiessling L.S. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998, 50:1618-1624.
57. Smith S.J., Lees A.J. Abnormalities of the blink reflex in Gilles de la Tourette syndrome. Journal of Neurology, Neurosurgery and Psychiatry 1989, 52:895-898.
58. Sobin C., Kiley-Brabeck K., Karayiorgou M. Lower prepulse inhibition in children with the 22q11 deletion syndrome. American Journal of Psychiatry 2005, 162:1090-1099.
59. Steeves T.D., Ko J.H., Kideckel D.M., Rusjan P., Houle S., Sandor P., Lang A.E., Strafella A.P. Extrastriatal dopaminergic dysfunction in Tourette syndrome. Annals of Neurology 2010, 67:170-181.
60. Sutherland Owens A.N., Miguel E.C., Swerdlow N.R. Sensory gating scales and premonitory urges in Tourette syndrome. TheScientificWorldJournal 2011, 11:736-741.
61. Swerdlow N.R. Are we studying and treating schizophrenia correctly?. Schizophrenia Research 2011, 130:1-10.
62. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensori-motor gating in patients with Obsessive Compulsive Disorder. Biological Psychiatry 1993, 33:298-301.
63. Swerdlow N.R., Bongiovanni M.J., Tochen L., Shoemaker J.M. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette syndrome. Psychopharmacology 2006, 186:246-254.
64. Swerdlow N.R., Light G.A., Cadenhead K.S., Sprock J., Hsieh M.H., Braff D.L. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Archives of General Psychiatry 2006, 63:1325-1335.
65. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry 1994, 51:139-154.
66. Swerdlow N.R., Caine S.B., Geyer M.A. Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology 1992, 108:189-195.
67. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001, 156:194-215.
68. Swerdlow N.R., Karban B., Ploum Y., Sharp R., Geyer M.A., Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's Syndrome: in search of an " fMRI-friendly" startle paradigm. Biological Psychiatry 2001, 50:578-585.
69. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's Disease. Journal of Neurology, Neurosurgery and Psychiatry 1995, 58:192-200.
70. Swerdlow N.R., Shilling P.D., Breier M., Trim R.S., Light G.A., Saint Marie R.L. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats. Psychopharmacology 2012, [epub ahead of print, June 15].
71. Swerdlow N.R., Stephany N., Shoemaker J.M., Ross L., Wasserman L.C., Talledo J., Auerbach P.P. Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology 2002, 164:82-92.
72. Swerdlow N.R., Sutherland A.N. Preclinical models relevant to Tourette syndrome. Advances in Neurology 2006, 99:69-88.
73. Swerdlow N.R., Sutherland A.N. Using animal models to develop therapeutics for Tourette syndrome. Pharmacology & Therapeutics 2005, 108:281-293.
74. Swerdlow N.R., van Bergeijk D.P., Bergsma F., Weber E., Talledo J. The effects of memantine on prepulse inhibition. Neuropsychopharmacology 2009, 34:1854-1864.
75. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 2008, 199:331-388.
76. Talledo J.A., Sutherland Owens A.N., Schortinghuis T., Swerdlow N.R. Amphetamine effects on startle gating in normal women and female rats. Psychopharmacology 2009, 204:165-175.
77. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58:527-536. Tourette's Syndrome Study Group.
78. Vaillancourt C., Boksa P. Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia. Neuropsychopharmacology 2000, 23:654-666.
79. Valls-Sole J., Munoz J.E., Valldeoriola F. Abnormalities of prepulse inhibition do not depend on blink reflex excitability: a study in Parkinson's disease and Huntington's disease. Clinical Neurophysiology 2004, 115:1527-1536.
80. van Rijn S., Swaab H., Magnée M., van Engeland H., Kemner C. Psychophysiological markers of vulnerability to psychopathology in men with an extra X chromosome (XXY). PLoS ONE 2011, 6:e20292.
81. Vollenweider F.X., Barro M., Csomor P.A., Feldon J. Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. Biological Psychiatry 2006, 60:597-603.
82. Wang Z., Maia T.V., Marsh R., Colibazzi T., Gerber A., Peterson B.S. The neural circuits that generate tics in Tourette's syndrome. American Journal of Psychiatry 2011, 168:1326-1337.
83. Welter M.L., Mallet L., Houeto J.L., Karachi C., Czernecki V., Cornu P., Navarro S., Pidoux B., Dormont D., Bardinet E., Yelnik J., Damier P., Agid Y. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Archives of Neurology 2008, 65:952-957.
84. Wilhelm S., Peterson A.L., Piacentini J., Woods D.W., Deckersbach T., Sukhodolsky D.G., Chang S., Liu H., Dziura J., Walkup J.T., Scahill L. Randomized trial of behavior therapy for adults with tourette syndrome. Arch Gen Psychiatry 69: 2012, 795-803.
85. Woods D.W., Himle M.B., Miltenberger R.G., Carr J.E., Osmon D.C., Karsten A.M., Jostad C., Bosch A. Durability, negative impact, and neuropsychological predictors of tic suppression in children with chronic tic disorder. Journal of Abnormal Child Psychology 2008, 36:237-245.
86. Zhang J., Forkstam C., Engel J.A., Svensson L. Role of dopamine in prepulse inhibition of acoustic startle. Psychopharmacology 2000, 149:181-188.
87. Ziemann U., Paulus W., Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. American Journal of Psychiatry 1997, 154:1277-1284.